{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T15:39:03Z","timestamp":1759333143733},"reference-count":34,"publisher":"Oxford University Press (OUP)","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,5,1]]},"DOI":"10.2146\/ajhp090118","type":"journal-article","created":{"date-parts":[[2010,4,21]],"date-time":"2010-04-21T19:34:12Z","timestamp":1271878452000},"page":"724-727","source":"Crossref","is-referenced-by-count":15,"title":["Herpes zoster and vaccination: A clinical review"],"prefix":"10.1093","volume":"67","author":[{"given":"Erin N.","family":"Adams","sequence":"first","affiliation":[{"name":"School of Pharmacy, Shenandoah University, Winchester, VA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah","family":"Parnapy","sequence":"additional","affiliation":[{"name":"School of Pharmacy, Shenandoah University, Winchester, VA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philip","family":"Bautista","sequence":"additional","affiliation":[{"name":"INOVA Fairfax, Falls Church, VA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","reference":[{"key":"2019041509083473800_b1-0670724","first-page":"1","article-title":"Prevention of herpes zoster: recommendations of the Advisory Committee on Immunization Practices (ACIP)","volume":"57","author":"Harpaz","year":"2008","journal-title":"MMWR"},{"key":"2019041509083473800_b2-0670724","doi-asserted-by":"crossref","first-page":"991","DOI":"10.2165\/0002512-200825120-00002","article-title":"Herpes zoster and postherpetic neuralgia: optimizing management in the elderly patient","volume":"25","author":"Johnson","year":"2008","journal-title":"Drugs Aging"},{"key":"2019041509083473800_b3-0670724","first-page":"2437","article-title":"Management of herpes zoster (shingles) and postherpetic neuralgia","volume":"61","author":"Stankus","year":"2000","journal-title":"Am Fam Physician"},{"key":"2019041509083473800_b4-0670724","doi-asserted-by":"crossref","first-page":"2266","DOI":"10.1056\/NEJMp058091","article-title":"Aging, immunity and the varicella-zoster virus","volume":"352","author":"Arvin","year":"2005","journal-title":"N Engl J Med"},{"key":"2019041509083473800_b5-0670724","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1001\/archderm.144.5.603","article-title":"Family history as a risk factor for herpes zoster: a case-control study","volume":"144","author":"Hicks","year":"2008","journal-title":"Arch Dermatol"},{"key":"2019041509083473800_b6-0670724","unstructured":"Merck & Co. Zoster incidence. www.merckvaccines.com\/diseaseInfo_frmst.html?\/diseases\/zoster\/zos_incidence (accessed 2009 May 4)."},{"key":"2019041509083473800_b7-0670724","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1056\/NEJMcp013211","article-title":"Herpes zoster","volume":"347","author":"Gnann","year":"2002","journal-title":"N Engl J Med"},{"key":"2019041509083473800_b8-0670724","unstructured":"Mayo Clinic. Shingles. www.mayoclinic.com\/health\/shingles\/DS00098 (accessed 2009 May 3)."},{"key":"2019041509083473800_b9-0670724","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1128\/CVI.00310-07","article-title":"A double-blind, randomized, controlled, multicenter safety and immunogenicity study of a refrigerator-stable formulation of Zostavax","volume":"15","author":"Gilderman","year":"2008","journal-title":"Clin Vaccine Immunol"},{"key":"2019041509083473800_b10-0670724","unstructured":"Centers for Disease Control and Prevention. Shingles disease\u2014questions and answers (herpes zoster). www.cdc.gov\/vaccines\/vpd-vac\/shingles\/dis-faqs.htm (accessed 2009 Apr 29)."},{"issue":"suppl 1","key":"2019041509083473800_b11-0670724","first-page":"S2","article-title":"The burden of herpes zoster and postherpetic neuralgia in the United States","volume":"107","author":"Weaver","year":"2007","journal-title":"J Am Osteopath Assoc"},{"issue":"suppl 1","key":"2019041509083473800_b12-0670724","doi-asserted-by":"crossref","first-page":"S83","DOI":"10.1086\/342970","article-title":"Consequences and management of pain in herpes zoster","volume":"186","author":"Johnson","year":"2002","journal-title":"J Infect Dis"},{"key":"2019041509083473800_b13-0670724","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1212\/01.WNL.0000140708.62856.72","article-title":"Practice parameter: treatment of post-herpetic neuralgia: an evidenced-based report of the quality standards subcommittee of the American Academy of Neurology","volume":"63","author":"Dubinsky","year":"2004","journal-title":"Neurology"},{"key":"2019041509083473800_b14-0670724","unstructured":"Mayo Clinic. Postherpetic neuralgia. www.mayoclinic.com\/health\/postherpetic-neuralgia\/DS00277 (accessed 2009 Jan 20)."},{"key":"2019041509083473800_b15-0670724","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1086\/421942","article-title":"Acute pain in herpes zoster and its impact on health-related quality of life","volume":"39","author":"Katz","year":"2004","journal-title":"Clin Infect Dis"},{"key":"2019041509083473800_b16-0670724","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2165\/00002512-200724010-00001","article-title":"Post-herpetic neuralgia in older adults: evidence-based approaches to clinical management","volume":"24","author":"Christo","year":"2007","journal-title":"Drugs Aging"},{"issue":"suppl 1","key":"2019041509083473800_b17-0670724","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1086\/510206","article-title":"Recommendations for the management of herpes zoster","volume":"44","author":"Dworkin","year":"2007","journal-title":"Clin Infect Dis"},{"key":"2019041509083473800_b18-0670724","unstructured":"Food and Drug Administration. Zostavax (herpes zoster vaccine) questions and answers. www.fda.gov\/BiologicsBloodVaccines\/Vaccines\/QuestionsaboutVaccines\/UCM070418 (accessed 2010 Jan 28)."},{"key":"2019041509083473800_b19-0670724","volume-title":"Zostavax (zoster vaccine live) prescribing information","year":"2008"},{"key":"2019041509083473800_b20-0670724","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1086\/528696","article-title":"Varicella-zoster virus-specific immune responses in elderly recipients of a herpes zoster vaccine","volume":"197","author":"Levin","year":"2008","journal-title":"J Infect Dis"},{"key":"2019041509083473800_b21-0670724","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1056\/NEJMct066061","article-title":"Varicella-zoster vaccine for the prevention of herpes zoster","volume":"356","author":"Kimberlin","year":"2007","journal-title":"N Engl J Med"},{"key":"2019041509083473800_b22-0670724","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1056\/NEJMoa051016","article-title":"A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults","volume":"352","author":"Oxman","year":"2005","journal-title":"N Engl J Med"},{"issue":"suppl 1","key":"2019041509083473800_b23-0670724","doi-asserted-by":"crossref","first-page":"S31","DOI":"10.1016\/j.jpain.2007.10.007","article-title":"Vaccination to prevent herpes zoster in older adults","volume":"9","author":"Gnann","year":"2008","journal-title":"J Pain"},{"key":"2019041509083473800_b24-0670724","unstructured":"Centers for Disease Control and Prevention. CDC vaccine price list. www.cdc.gov\/vaccines\/programs\/vfc\/cdc-vac-price-list.htm (accessed 2009 Feb 10)."},{"key":"2019041509083473800_b25-0670724","unstructured":"Centers for Medicare and Medicaid Services. Medicare preventative services quick reference information: Medicare Part B immunization billing. www.cms.hhs.gov\/mlnproducts\/downloads\/qr_immun_bill.pdf (accessed 2009 Feb 1)."},{"key":"2019041509083473800_b26-0670724","unstructured":"Merck & Co. Pathways to reimbursement for Zostavax. www.merckvaccines.com\/vaccines\/zostavax\/pathwaysToReimbursement.pdf (accessed 2010 Jan 26)."},{"key":"2019041509083473800_b27-0670724","first-page":"33","article-title":"Billing for Medicare Part D vaccines","volume":"14","author":"Moore","year":"2007","journal-title":"Fam Pract Manag"},{"key":"2019041509083473800_b28-0670724","unstructured":"Centers for Disease Control and Prevention. Herpes zoster vaccine Q&A (shingles). www.cdc.gov\/vaccines\/vpd-vac\/shingles\/vac-faqs.htm (accessed 2009 Feb 1)."},{"key":"2019041509083473800_b29-0670724","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1111\/j.1526-4637.2006.00196.x","article-title":"Health care expenditure burden of persisting herpes zoster pain","volume":"9","author":"Dworkin","year":"2008","journal-title":"Pain Med"},{"key":"2019041509083473800_b30-0670724","doi-asserted-by":"crossref","first-page":"317","DOI":"10.7326\/0003-4819-145-5-200609050-00004","article-title":"Cost-effectiveness of a vaccine to prevent herpes zoster and postherpetic neuralgia in older adults","volume":"145","author":"Hornberger","year":"2006","journal-title":"Ann Intern Med"},{"key":"2019041509083473800_b31-0670724","doi-asserted-by":"crossref","first-page":"8326","DOI":"10.1016\/j.vaccine.2007.09.066","article-title":"Evaluation of the cost-effectiveness in the United States of a vaccine to prevent herpes zoster and postherpetic neuralgia in older adults","volume":"25","author":"Pellissier","year":"2007","journal-title":"Vaccine"},{"key":"2019041509083473800_b32-0670724","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1086\/514342","article-title":"Cost-effectiveness of a vaccine to prevent herpes zoster and post-herpetic neuralgia in older adults","volume":"44","author":"Rothberg","year":"2007","journal-title":"Clin Infect Dis"},{"key":"2019041509083473800_b33-0670724","volume-title":"Zostavax prescribing information","author":"Merck & Co","year":"2009"},{"key":"2019041509083473800_b34-0670724","doi-asserted-by":"crossref","article-title":"Concomitant administration of zoster and pneumococcal vaccines in adults \u2265 60 years old","author":"MacIntyre","DOI":"10.4161\/hv.6.11.12852"}],"container-title":["American Journal of Health-System Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/ajhp\/article-pdf\/67\/9\/724\/28424680\/ajhp0724.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,15]],"date-time":"2019-04-15T09:55:35Z","timestamp":1555322135000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ajhp\/article\/67\/9\/724\/5130106"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,5,1]]},"references-count":34,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2010,5,1]]}},"URL":"https:\/\/doi.org\/10.2146\/ajhp090118","relation":{},"ISSN":["1079-2082","1535-2900"],"issn-type":[{"value":"1079-2082","type":"print"},{"value":"1535-2900","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2010,5,1]]},"published":{"date-parts":[[2010,5,1]]}}}